Pfizer’s experimental vaccine showed “extraordinary” early results from final stage trials, raising hopes of a potential end to the nearly year-long pandemic but its supply and delivery will be an enormous and daunting logistical challenge.
Posted from: this blog via Microsoft Flow.
No comments:
Post a Comment